SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-24-196006
Filing Date
2024-08-07
Accepted
2024-08-07 17:03:57
Documents
11

Document Format Files

Seq Description Document Type Size
1 SC14D9C d856692dsc14d9c.htm SC14D9C 20961
2 EX-99.1 d856692dex991.htm EX-99.1 11995
3 EX-99.2 d856692dex992.htm EX-99.2 70244
4 EX-99.3 d856692dex993.htm EX-99.3 24119
5 EX-99.4 d856692dex994.htm EX-99.4 10294
6 EX-99.5 d856692dex995.htm EX-99.5 10479
7 EX-99.6 d856692dex996.htm EX-99.6 7923
8 EX-99.7 d856692dex997.htm EX-99.7 8576
9 EX-99.8 d856692dex998.htm EX-99.8 10714
10 GRAPHIC g856692g0808003440900.jpg GRAPHIC 20066
11 GRAPHIC g856692g0808003900209.jpg GRAPHIC 20066
  Complete submission text file 0001193125-24-196006.txt   232835
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filed by) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Subject) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-90214 | Film No.: 241184883
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)